Maturing papillomatous nevoid melanoma in the scalp mimicking recurrent melanocytic nevus: A case report of previously undescribed subtype of nevoid melanoma
暂无分享,去创建一个
S. Ogawa | C. Shea | H. Haga | Yosuke Yamada | Y. Ishida | M. Fujimoto | Y. Takeuchi | Y. Kaku | S. Usui | Marina Tsujimura
[1] P. Googe,et al. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms , 2021, The American Journal of dermatopathology.
[2] K. Ichimura,et al. Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma , 2020, Modern Pathology.
[3] B. Wood,et al. Mitotically Active Nevus and Nevoid Melanoma: A Clinicopathological and Molecular Study. , 2020, The American Journal of dermatopathology.
[4] J. Wilmott,et al. Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in Pregnancy , 2019, The American journal of surgical pathology.
[5] A. Halpern,et al. Massively parallel sequencing analysis of benign melanocytic naevi , 2019, Histopathology.
[6] N. Le Stang,et al. MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma , 2019, Modern Pathology.
[7] D. Elder,et al. WHO classification of skin tumours , 2018 .
[8] S. Miyano,et al. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. , 2017, Blood.
[9] R. Dummer,et al. The Genetic Evolution of Melanoma from Precursor Lesions. , 2015, The New England journal of medicine.
[10] K. Busam,et al. Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma , 2015, Journal of cutaneous pathology.
[11] Z. Szallasi,et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] Yu Fang,et al. Fluorescence in Situ Hybridization for Distinguishing Nevoid Melanomas From Mitotically Active Nevi , 2009, The American journal of surgical pathology.
[13] A. Bosserhoff,et al. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. , 2003, The American journal of pathology.
[14] J. Grichnik,et al. Malignant Melanoma With Paradoxical Maturation , 2000, The American journal of surgical pathology.
[15] M. Bulyk,et al. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. , 1996, Cancer research.
[16] E. Hovig,et al. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. , 1996, British Journal of Cancer.